https://orcid.org/0000-0002-6681-9882
Figures & data
Figure 1. Patient-level simulation model schematic.
Note: References have been supplied for the simplified TableCitation29 and Ganzoni TableCitation31
Abbreviations. IBD, inflammatory bowel disease; QoL, quality of life.
Figure 2. Resource utilisation associated with iron infusions, phosphate monitoring and phosphate replenishment.
Illustrative costs are from the Department of Health and Social Care perspective.
Table 1. Baseline patient characteristics and disease parameters.
Table 2. Key health economic results from the base case, micro-costing analysis, and societal perspective analysis.
Table 3. Cost breakdown for the base case, micro-costing analysis, and societal perspective analysis.
Figure 3. Scatterplot from probabilistic sensitivity analysis showing the incremental cost and quality-adjusted life year outcomes with ferric derisomaltose versus ferric carboxymaltose from the DHSC, provider, and societal perspectives.
Abbreviations. DHSC, Department of Health and Social Care; GBP, pounds sterling; QALYs, quality-adjusted life years.
Figure 4. Results from one-way sensitivity analysis around the base case analysis from the DHSC perspective.
Abbreviations. DHSC, Department of Health and Social Care; FDI, ferric derisomaltose; GBP, pounds sterling; ICUR, incremental cost-utility ratio; IDA, iron deficiency anemia.
